Azevan Pharmaceuticals, Inc.
Records under this name other than the patents Azevan Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 5 of 5 · Back to Azevan Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,987,265 | Methods for treating post traumatic stress disorder Lapsed on the fee record Ended Jun 5, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 5, 2026 | From the USPTO record |
| US 8,426,400 | β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists Lapsed on the fee record Ended Apr 23, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 23, 2025 | From the USPTO record |
| US 9,597,314 | Beta-lactamylalkanoic acids for treating premenstrual disorders Lapsed on the fee record Ended Mar 21, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 21, 2025 | From the USPTO record |
| US 7,119,083 | β-Lactamyl vasopressin V1a Antagonists Term ended Term ended Oct 11, 2022 · From the USPTO record | Term ended | Term ended Oct 11, 2022 | From the USPTO record |
| US 7,268,125 | β-lactamyl vasopressin V1a antagonists Formerly held Term ended Term ended Oct 11, 2022 · From the USPTO record | Term ended | Term ended Oct 11, 2022 | From the USPTO record |